HistoSonics, a medical technology company backed by Johnson & Johnson (NYSE:JNJ), is exploring a potential sale at a valuation of more than $2.5 billion after receiving multiple takeover offers, the Financial Times reported on Friday.
Medtronic (MDT), GE HealthCare (